Shu‐Hui Wen

1.2k total citations
62 papers, 840 citations indexed

About

Shu‐Hui Wen is a scholar working on Surgery, Gastroenterology and Molecular Biology. According to data from OpenAlex, Shu‐Hui Wen has authored 62 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 12 papers in Gastroenterology and 8 papers in Molecular Biology. Recurrent topics in Shu‐Hui Wen's work include Gastroesophageal reflux and treatments (11 papers), Eosinophilic Esophagitis (9 papers) and Genetic Associations and Epidemiology (7 papers). Shu‐Hui Wen is often cited by papers focused on Gastroesophageal reflux and treatments (11 papers), Eosinophilic Esophagitis (9 papers) and Genetic Associations and Epidemiology (7 papers). Shu‐Hui Wen collaborates with scholars based in Taiwan, China and United States. Shu‐Hui Wen's co-authors include Kuo‐Liang Yang, Meng‐Jiun Lai, Chien‐Lin Chen, Chia‐Liang Wu, Wei‐Yi Lei, Teng‐Yi Lin, Py‐Yu Lin, Wei‐Chuan Chang, Tso‐Tsai Liu and Chih‐Hsun Yi and has published in prestigious journals such as PLoS ONE, Scientific Reports and Radiology.

In The Last Decade

Shu‐Hui Wen

61 papers receiving 816 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu‐Hui Wen Taiwan 19 206 178 146 114 105 62 840
M.H. Otten Netherlands 18 251 1.2× 521 2.9× 114 0.8× 132 1.2× 62 0.6× 42 1.1k
T. Bistritzer Israel 16 191 0.9× 59 0.3× 44 0.3× 70 0.6× 92 0.9× 52 822
Valeria Dipasquale Italy 15 184 0.9× 33 0.2× 96 0.7× 73 0.6× 61 0.6× 80 821
María Pilar Cruz-Domínguez Mexico 16 126 0.6× 66 0.4× 47 0.3× 214 1.9× 67 0.6× 64 890
A. Guérin United States 11 76 0.4× 32 0.2× 59 0.4× 133 1.2× 134 1.3× 42 858
Yiwei Liu China 17 140 0.7× 171 1.0× 19 0.1× 76 0.7× 187 1.8× 49 1.1k
Juan F. Gallegos‐Orozco United States 19 388 1.9× 32 0.2× 138 0.9× 41 0.4× 112 1.1× 49 2.1k
Konstantinos Thomopoulos Greece 20 296 1.4× 33 0.2× 49 0.3× 121 1.1× 151 1.4× 66 1.3k
Amisha Patel United States 18 298 1.4× 37 0.2× 32 0.2× 197 1.7× 119 1.1× 60 1.3k
Christoph Bidlingmaier Germany 21 164 0.8× 1.1k 6.2× 27 0.2× 155 1.4× 143 1.4× 64 2.0k

Countries citing papers authored by Shu‐Hui Wen

Since Specialization
Citations

This map shows the geographic impact of Shu‐Hui Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Hui Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Hui Wen more than expected).

Fields of papers citing papers by Shu‐Hui Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Hui Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Hui Wen. The network helps show where Shu‐Hui Wen may publish in the future.

Co-authorship network of co-authors of Shu‐Hui Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Hui Wen. A scholar is included among the top collaborators of Shu‐Hui Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Hui Wen. Shu‐Hui Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Yixin, et al.. (2025). Resveratrol alleviates testicular toxicity induced by anti-PD-1 through regulating the NRF2-SLC7A11-GPX4 pathway. Frontiers in Immunology. 16. 1529991–1529991. 3 indexed citations
3.
Li, Yawen, Yixin Zhao, Xingyu Liu, et al.. (2024). The new era of lung cancer therapy: Combining immunotherapy with ferroptosis. Critical Reviews in Oncology/Hematology. 198. 104359–104359. 8 indexed citations
4.
Wen, Shu‐Hui, et al.. (2023). Impact of interhospital transfer on emergency department timeliness of care and in-hospital outcomes of adult non-trauma patients. Heliyon. 9(2). e13393–e13393. 1 indexed citations
6.
Chang, Wei‐Chuan, et al.. (2022). Chinese Herbal Medicines Have Potentially Beneficial Effects on the Perinatal Outcomes of Pregnant Women. Frontiers in Pharmacology. 13. 831690–831690. 5 indexed citations
7.
Hsieh, Wanhua Annie, et al.. (2021). Sex-Specific Temporal Trends in Overweight and Obese Among Schoolchildren From 2009 to 2018: An Age Period Cohort Analysis. Frontiers in Pediatrics. 9. 615483–615483. 7 indexed citations
8.
Lei, Wei‐Yi, Wei‐Chuan Chang, Shu‐Hui Wen, et al.. (2018). Impact of concomitant dyspepsia and irritable bowel syndrome on symptom burden in patients with gastroesophageal reflux disease. Journal of the Formosan Medical Association. 118(4). 797–806. 13 indexed citations
9.
Lei, Wei‐Yi, Wei‐Chuan Chang, Ming‐Wun Wong, et al.. (2018). Sleep Disturbance and Its Association with Gastrointestinal Symptoms/Diseases and Psychological Comorbidity. Digestion. 99(3). 205–212. 31 indexed citations
10.
Lei, Wei‐Yi, Jen‐Hung Wang, Shu‐Hui Wen, et al.. (2017). Risk of acute myocardial infarction in patients with gastroesophageal reflux disease: A nationwide population-based study. PLoS ONE. 12(3). e0173899–e0173899. 21 indexed citations
11.
Hsu, Ching‐Sheng, Shu‐Hui Wen, Jui‐Sheng Hung, et al.. (2017). Overlap of Dyspepsia in Patients with Gastroesophageal Reflux Disease: Impact of Clinical, Metabolic, and Psychosocial Characteristics. Digestive Diseases and Sciences. 62(4). 994–1001. 18 indexed citations
12.
Chen, Jiann‐Hwa, Shu‐Hui Wen, Ching‐Sheng Hsu, et al.. (2016). Clinical characteristics and psychosocial impact of different reflux time in gastroesophageal reflux disease patients. Journal of the Formosan Medical Association. 116(2). 123–128. 3 indexed citations
13.
Wu, Chia‐Liang & Shu‐Hui Wen. (2016). A 10-year follow-up study of the association between calcium channel blocker use and the risk of dementia in elderly hypertensive patients. Medicine. 95(32). e4593–e4593. 26 indexed citations
14.
Wu, Hsin-Chi, et al.. (2015). Update of the normative data for the Chinese Child Development Inventory for children over 3 years old. Tzu Chi Medical Journal. 27(1). 25–34. 1 indexed citations
15.
Lei, Wei‐Yi, Shu‐Hui Wen, Tso‐Tsai Liu, et al.. (2014). Predictive factors of silent reflux in subjects with erosive esophagitis. Digestive and Liver Disease. 47(1). 24–29. 18 indexed citations
16.
Wen, Shu‐Hui & Jih‐I Yeh. (2014). Cohen’s h for detection of disease association with rare genetic variants. BMC Genomics. 15(1). 875–875. 4 indexed citations
17.
Wen, Shu‐Hui, et al.. (2011). Associations among birth weight, placental weight, gestational period and product quality indicators of umbilical cord blood units. Transfusion and Apheresis Science. 46(1). 39–45. 31 indexed citations
18.
Wen, Shu‐Hui, et al.. (2009). Iatrogenic colonic perforation by colonoscopy: a fatal complication for patients with a high anesthetic risk. International Journal of Colorectal Disease. 25(4). 449–454. 22 indexed citations
19.
Wen, Shu‐Hui, Meng‐Jiun Lai, & Kuo‐Liang Yang. (2008). Human leukocyte antigen-A, -B, and -DRB1 haplotypes of cord blood units in the Tzu Chi Taiwan Cord Blood Bank. Human Immunology. 69(7). 430–436. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026